# Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis

> **NCT00760864** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 432 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** TAK-715 and methotrexate
- **DRUG:** TAK-715 and methotrexate
- **DRUG:** TAK-715 and methotrexate
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00760864
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 432 (ACTUAL)
- **Last updated:** 2010-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760864, "Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00760864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*